Health-care companies ticked up as deal activity continued.
British drug giant GSK agreed to buy biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline. The deal follows multibillion-dollar tie-up plans from Boston Scientific, Novartis and others.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-09-24 1851ET